These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33443602)

  • 1. Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.
    Alongi P; Stefano A; Comelli A; Laudicella R; Scalisi S; Arnone G; Barone S; Spada M; Purpura P; Bartolotta TV; Midiri M; Lagalla R; Russo G
    Eur Radiol; 2021 Jul; 31(7):4595-4605. PubMed ID: 33443602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study.
    Alongi P; Laudicella R; Stefano A; Caobelli F; Comelli A; Vento A; Sardina D; Ganduscio G; Toia P; Ceci F; Mapelli P; Picchio M; Midiri M; Baldari S; Lagalla R; Russo G
    Q J Nucl Med Mol Imaging; 2022 Dec; 66(4):352-360. PubMed ID: 32543166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.
    Russo G; Stefano A; Alongi P; Comelli A; Catalfamo B; Mantarro C; Longo C; Altieri R; Certo F; Cosentino S; Sabini MG; Richiusa S; Barbagallo GMV; Ippolito M
    Curr Oncol; 2021 Dec; 28(6):5318-5331. PubMed ID: 34940083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
    Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
    Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
    Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P
    Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of radiomics based on
    Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-based analysis of [
    Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
    Graziani T; Ceci F; Castellucci P; Polverari G; Lima GM; Lodi F; Morganti AG; Ardizzoni A; Schiavina R; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1971-9. PubMed ID: 27277279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous
    Tu SJ; Tran VT; Teo JM; Chong WC; Tseng JR
    Med Phys; 2021 Sep; 48(9):5192-5201. PubMed ID: 34214211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
    Zhong J; Frood R; Brown P; Nelstrop H; Prestwich R; McDermott G; Currie S; Vaidyanathan S; Scarsbrook AF
    Clin Radiol; 2021 Jan; 76(1):78.e9-78.e17. PubMed ID: 33036778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary PET radiomics study of brain metastases using a fully automatic segmentation method.
    Stefano A; Comelli A; Bravatà V; Barone S; Daskalovski I; Savoca G; Sabini MG; Ippolito M; Russo G
    BMC Bioinformatics; 2020 Sep; 21(Suppl 8):325. PubMed ID: 32938360
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of
    Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
    Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Laudicella R; Comelli A; Liberini V; Vento A; Stefano A; Spataro A; Crocè L; Baldari S; Bambaci M; Deandreis D; Arico' D; Ippolito M; Gaeta M; Alongi P; Minutoli F; Burger IA; Baldari S
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist
    Wieser G; Popp I; Christian Rischke H; Drendel V; Grosu AL; Bartholomä M; Weber WA; Mansi R; Wetterauer U; Schultze-Seemann W; Meyer PT; Jilg CA
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1463-1472. PubMed ID: 28417160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
    Agüloğlu N; Aksu A; Unat DS
    Nucl Med Commun; 2023 Apr; 44(4):302-308. PubMed ID: 36756766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics Analysis of Brain [
    Alongi P; Laudicella R; Panasiti F; Stefano A; Comelli A; Giaccone P; Arnone A; Minutoli F; Quartuccio N; Cupidi C; Arnone G; Piccoli T; Grimaldi LME; Baldari S; Russo G
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.